Open AccessThiazolidinediones as Therapy for Endometriosis: A Case Series
Author(s) -
Molly B. Moravek,
Elizabeth A. Ward,
Dan I. Lebovic
Publication year - 2009
Publication title -
gynecologic and obstetric investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 63
eISSN - 1423-002X
pISSN - 0378-7346
DOI - 10.1159/000230713
Subject(s) - endometriosis , medicine , rosiglitazone , clinical trial , ovulation , prospective cohort study , gynecology , hormone , receptor
Current medical therapies for endometriosis result in delayed conception and have not been shown to provide any fertile benefit subsequent to treatment. Thiazolidinediones (TZDs) do not impede conception and have been shown to reduce endometriotic lesions in animal models; however, no studies have been performed in humans. The aim of this study was to provide preliminary data about the effectiveness of a TZD in treating endometriosis-related pain.